Orphan nuclear receptor small heterodimer partner (SHP)is an atypical member of the nuclear receptor superfamily; SHP regulates the nuclear receptor-mediated transcription of target genes but lacks a conventional DNA binding domain. In this study, we demonstrate that SHP represses transforming growth factor- (TGF-)-induced gene expression through a direct interaction with Smad, a transducer of TGF- signaling. Transient transfection studies demonstrate that SHP represses Smad3-induced transcription. In vivo and in vitro protein interaction assays revealed that SHP directly interacts with Smad2 and Smad3 but not with Smad4. Mapping of domains mediating the interaction between SHP and Smad3 showed that the entire N-terminal domain (1-159 amino acids) of SHP and the linker domain of Smad3 are involved in this interaction. In vitro glutathione S-transferase pulldown competition experiments revealed the SHP-mediated repression of Smad3 transactivation through competition with its co-activator p300. SHP also inhibits the activation of endogenous TGF--responsive gene promoters, the p21, Smad7, and plasminogen activator inhibitor-1 (PAI-1) promoters. Moreover, adenovirus-mediated overexpression of SHP decreases PAI-1 mRNA levels, and down-regulation of SHP by a small interfering RNA increases both the transactivation of Smad3 and the PAI-1 mRNA levels. Finally, the PAI-1 gene is expressed in SHP ؊/؊ mouse hepatocytes at a higher level than in normal hepatocytes. Taken together, these data indicate that SHP is a novel co-regulator of Smad3, and this study provides new insights into regulation of TGF- signaling.
SHP3 is an atypical member of the orphan nuclear receptor superfamily because its lacks a conventional DBD (1). SHP represses the transcriptional activity of various nuclear receptors, including the estrogen receptor (ER), constitutive androstane receptor, thyroid receptor, retinoic acid receptor, retinoid X receptor, hepatocyte nuclear factor 4␣, androgen receptor (AR), liver receptor homolog-1, estrogenrelated receptor ␥ (ERR␥), glucocorticoid receptor (GR), pregnane X receptor, hepatocyte nuclear factor 3, and Nur77 (1-14), via direct physical interactions. Moreover, SHP acts as a co-repressor of transcription factors, such as the basic helix-loop-helix-Per-Arnt-Sim domain protein, AhR nuclear translocator (ARNT), and basic helix-loop-helix protein BETA2 (15, 16). However, it remains to be determined whether SHP regulates cytokine-mediated cell signaling or other signaling pathways.The mechanism of repression by SHP is not clearly understood. However, previous reports have suggested that SHP represses transcription factor-mediated transactivation by inhibition of DNA binding (1,12,13), recruitment of unknown co-repressors (5, 6, 9) or histone deacetylases (17), or through interactions with EID-1 (18). Moreover, several reports have demonstrated that repression by SHP may involve competition with co-activators, such as TIF2, PGC-1, and p300 (10 -12, 14, 16). SHP is expressed in a variety of tissues, includi...